Aptevo Therapeutics Inc. (APVO) Expected Move

Expected move estimates the probable price range for a given period based on at-the-money options pricing. It reflects the market consensus for volatility over the selected timeframe.

Aptevo Therapeutics Inc. (APVO) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $10.0M, listed on NASDAQ, employing roughly 33 people, carrying a beta of 1.67 to the broader market. Aptevo Therapeutics Inc. Led by Jeffrey G. Lamothe, public since 2016-07-20.

Expected move analysis estimates the probable price range implied by options pricing. No recent options activity for APVO as of 2026-07-17; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how expected move is reported and how to read the data →